Dr. Michel Koren and Dr. Mitchell Rothstein host a presentation in front of a live audience to discuss the current state of gene editing. The doctoral duo discuss developments including new-to-market medical therapies, clinical trials, and the legal issues surrounding gene therapy patents. They also explain the difference between gene silencing techniques, which temporarily stop genes from creating proteins, and gene editing techniques which permanently alter the genome. They also touch on controversies, risks, and the comprehensive considerations that take place before a participant can partake in a gene editing clinical trial.
Podden och tillhörande omslagsbild på den här sidan tillhör
Dr. Michael Koren. Innehållet i podden är skapat av Dr. Michael Koren och inte av,
eller tillsammans med, Poddtoppen.
